Mice receiving adoptively transferred bystander-activated CD8+ T cells showed a significant delay in disease progression as assessed by clinical scoring and survival and exhibited significantly lower viral titers than the control mice on day 1 after infection (Figure 4, C–E), suggesting an involvement of bystander-activated CD8+ T cells in reducing the early viral burden. Here, CD8A is linked to infection.